All stock lists
Nektar Therapeutics (NASDAQ:NKTR)
US · Delayed Price · Currency is USD
Also listed: 0UNL.LHealthcare · Biotechnology
37.28+0.07 (+0.17%)
Insider Score
––Not scored
NKTR Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
NKTR Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 10.13 M | 10.86 M | 21.81 M | 11.79 M | 11.18 M | 10.46 M |
| Revenue Growth (YoY) | -9.34 % | 3.83 % | -25.25 % | -51.13 % | -52.42 % | -51.66 % |
| Cost of Revenue | 0.00 | 151.00 K | 0.00 | 196.00 K | 0.00 | 0.00 |
| Gross Profit | 10.13 M | 10.71 M | 21.81 M | 11.59 M | 11.18 M | 10.46 M |
| SG&A Expense | 12.77 M | 13.29 M | 11.38 M | 15.87 M | 17.07 M | 24.35 M |
| R&D Expense | 39.13 M | 35.68 M | 29.71 M | 27.25 M | 29.89 M | 30.48 M |
| Operating Expenses | 52.47 M | 48.97 M | 40.90 M | 43.13 M | 47.41 M | 54.99 M |
| Operating Income | -42.34 M | -38.26 M | -19.09 M | -31.53 M | -36.23 M | -44.53 M |
| Pretax Income | -40.30 M | -44.84 M | -36.05 M | -35.55 M | -41.78 M | -50.83 M |
| Tax Provision | 2.00 K | 64.00 K | 31.00 K | -33.00 K | -188.00 K | 52.00 K |
| Net Income | -40.62 M | -44.90 M | -36.08 M | -35.52 M | -41.59 M | -50.88 M |
| EPS (Basic) | -1.23 | -1.82 | -1.78 | -1.87 | -2.95 | -3.62 |
| EPS (Diluted) | -1.23 | -1.82 | -1.78 | -1.87 | -2.95 | -3.62 |
| Shares Outstanding | 33.05 M | 24.74 M | 20.30 M | 14.09 M | 14.09 M | 14.06 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.